Profile for Protection, Effectiveness, along with Pharmacokinetics associated with Almonertinib (HS-10296) in Pretreated Sufferers Along with EGFR-Mutated Innovative NSCLC: A new Multicenter, Open-label, Stage One particular Trial. (brawave62)